Genentech Susvimo Ocular Implant Recall: Defective Delivery System Risk

Take action

Contact the company & request your remedy

Recalling firmGenentech Inc1 Dna Way, N/A · South San Francisco, CA 94080-4918

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Genentech is recalling Susvimo (ranibizumab injection) because some implants have become non-functional due to a defective delivery system. This could affect patients receiving treatment for eye conditions.

Why it’s dangerous

The defective delivery system causes some implants to become non-functional after use. This means the treatment may not work as intended for patients receiving eye treatments.

Who’s affected

Patients using Susvimo for eye conditions who have the recalled lots. Those with the specific lot numbers listed in the recall are most at risk.

How to tell if you have this one

Check the lot number on the Susvimo carton. Recalled lots include: 3499188 (exp 10/31/2022), 3523071 (exp 6/30/2023), and several others expiring through 2027.

Brand
Genentech
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Lot Number
Look for the lot number on the Susvimo carton to determine if it's in the recalled list.

✎ GovInfoNow

Questions people ask

Why is this product being recalled?

The recall is for defective delivery systems that cause some implants to become non-functional.

What should I do if I have the recalled product?

Check the lot number on the carton to see if it's in the recalled list. If it is, contact Genentech for instructions.

Is there a risk of serious injury from this product?

The recall states the implants become non-functional, but there is no mention of injury risk in normal use.

Take action

Contact Genentech

We’ve drafted a message you can send Genentech to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0025-2023 — Genentech Genentech

Hello,

I own a Genentech that is covered by recall D-0025-2023 from Genentech.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0025-2023 (October 18, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0025-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Genentech Inc recalls Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One Susvimo single-dose vial and One

Lower-risk recall